IDO1 and COVID-19: Targeted and untargeted metabolomic analyses have also identified altered tryptophan metabolism in the kynurenine pathways of COVID-19 patients.71,72 These metabolic alterations are thought to result from cytokine storms that activate the enzyme IDO-1, increasing kynurenine metabolites.